Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-02

Clinical Trial Update: Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic Dermatitis [Phase 4]

View source ↗

Summary

A Phase 4 trial is comparing the safety and effectiveness of Crisaborole Ointment 2% versus Tacrolimus Ointment 0.1% for topical treatment of atopic dermatitis;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Crisaborole Ointment (2%) (crisaborole)
  • Tacrolimus Ointment (0.1%) (tacrolimus)

Snippet

Sponsor: Hayat Abad Medical Complex, Peshawar | Conditions: Atopic Dermatitis | Phase 4 | Status: NOT_YET_RECRUITING